Beam gene therapy restores glucose production

Biotechnology company Beam Therapeutics announced that its experimental one-time base editing treatment, BEAM-301, has successfully restored endogenous glucose production in early patients with glycogen storage disease type Ia. Patients in the highest dose cohort safely fasted for 15 hours while reducing cornstarch consumption by up to 92 percent.

Microsoft announces “Dragon Copilot” for the healthcare sector

مايكروسوفت دراغون كوبيلوت

Microsoft has launched “Microsoft Dragon Copilot” to serve the healthcare sector, automatically recording medical notes and providing reliable information in real-time. This technological leap aims to ease the burdens on physicians and empower them to focus on patient care.